BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2542107)

  • 1. Alloxan diabetogenicity: determinants of potentiation, protection and B-cell selectivity.
    Boquist L
    Diabete Metab; 1989; 15(1):23-9. PubMed ID: 2542107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alloxan on the islets of Langerhans: stimulation and inhibition of cyclic AMP production.
    Borg LA; Bone AJ
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):361-9. PubMed ID: 2993386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the beta-cell sensitivity to alloxan in vivo. Influence of pre- and post-treatment with protective substances.
    Boquist L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):556-61. PubMed ID: 354301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic B-cell sensitivity to alloxan in vivo. A study of antagonizing compounds, serum inorganic phosphate and acid-base balance.
    Boquist L
    Acta Pathol Microbiol Scand A; 1978 Jul; 86(4):313-8. PubMed ID: 362804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro.
    Boquist L; Nelson L; Lorentzon R
    Endocrinology; 1983 Sep; 113(3):943-8. PubMed ID: 6347668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocrine pancreas in early alloxan diabetes. Including study of the alloxan inhibitory effect of feeding and some hexoses.
    Boquist L
    Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):219-29. PubMed ID: 322443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct effects of diazoxide on mitochondria in pancreatic B-cells and on isolated liver mitochondria.
    Grimmsmann T; Rustenbeck I
    Br J Pharmacol; 1998 Mar; 123(5):781-8. PubMed ID: 9535004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloxan effects on mitochondria in vitro, studied with regard to inhibition of mitochondrial aconitase.
    Boquist L; Boström T
    Diabete Metab; 1985 Aug; 11(4):232-7. PubMed ID: 4043490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptozotocin diabetes. Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide.
    Anderson T; Schein PS; McMenamin MG; Cooney DA
    J Clin Invest; 1974 Sep; 54(3):672-7. PubMed ID: 4369217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metabolic alkalosis on the B-cell sensitivity to alloxan in vivo.
    Boquist L
    Horm Metab Res; 1978 Nov; 10(6):477-81. PubMed ID: 33888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p-Hydroxymercuribenzoate-induced hyperglycemia: influence of pre- and post-treatment with L-leucine, tolbutamide, D-mannoheptulose, insulin and alloxan.
    Boquist L
    J Endocrinol Invest; 1979; 2(4):413-7. PubMed ID: 395187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tilapia islet grafts are highly alloxan-resistant.
    Xu BY; Morrison CM; Yang H; Wright JR
    Gen Comp Endocrinol; 2004 Jun; 137(2):132-40. PubMed ID: 15158125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinamide does not protect islet B-cell metabolism against alloxan toxicity.
    Sandler S; Welsh M; Andersson A
    Diabetes; 1984 Oct; 33(10):937-43. PubMed ID: 6237009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA strand breaks and poly(ADP-ribose) synthetase activation in pancreatic islets--a new aspect to development of insulin-dependent diabetes and pancreatic B-cell tumors.
    Okamoto H; Yamamoto H
    Princess Takamatsu Symp; 1983; 13():297-308. PubMed ID: 6317640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncarbohydrate nutrients protect against alloxan-induced inhibition of insulin release.
    Sener A; Malaisse-Lagae F; Malaisse WJ
    Endocrinology; 1982 Jun; 110(6):2210-2. PubMed ID: 7042326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting modes of action of D-glucose and 3-O-methyl-D-glucose as protectors of the rat pancreatic B-cell against alloxan.
    Malaisse-Lagae F; Sener A; Malaisse WJ
    Biochim Biophys Acta; 1983 Feb; 762(1):36-43. PubMed ID: 6338936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alloxan on the islets of Langerhans: inhibition of leucine metabolism and insulin secretion.
    Borg LA
    Biochim Biophys Acta; 1981 Oct; 677(2):257-62. PubMed ID: 7028133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of alloxan on the content of insulin and zinc in the pancreatic islets in experimental animals].
    Lapin VI; Korchin VI; Meiramov GG; Pal'mina TV; Satosin VF
    Patol Fiziol Eksp Ter; 1973; 17(4):36-40. PubMed ID: 4590866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.